Last update 08 May 2025

TBXA2R x VDCCs x VEGFR3

Basic Info

Related Targets
TBXA2RVDCCsVEGFR3

Related

1
Drugs associated with TBXA2R x VDCCs x VEGFR3
Dauricine
Target
TBXA2R x VDCCs x VEGFR3
Mechanism
TBXA2R antagonists [+2]
Active Org.
Xi'an Jiaotong UniversityXi'an Jiaotong University
Originator Org.
Wuhan Medical College
Active Indication
Non-Small Cell Lung Cancer
Inactive Indication
Arrhythmias, Cardiac [+1]
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with TBXA2R x VDCCs x VEGFR3
Login to view more data
100 Translational Medicine associated with TBXA2R x VDCCs x VEGFR3
Login to view more data
0 Patents (Medical) associated with TBXA2R x VDCCs x VEGFR3
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free